Access is unequal to weight-loss drugs Ozempic and Wegovy: study

Prescriptions for blockbuster drugs that treat diabetes, obesity and heart disease are soaring, but the mix of payers shows access to the drugs is far from equitable, per a study published in JAMA Health Forum.

Why it matters: Patients on Medicare and Medicaid appear less likely to be able to access the drugs than those with private coverage.